3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
38
Breast Neoplasms
31
Lung Neoplasms
25
Colorectal Neoplasms
15
Prostatic Neoplasms
13
Pancreatic Neoplasms
11
Ovarian Neoplasms
11
Head and Neck Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Sarcoma
8
Colonic Neoplasms
8
Uterine Cervical Neoplasms
7
Melanoma
7
Glioma
7
Esophageal Neoplasms
7
Carcinoma, Hepatocellular
7
Lymphoma
6
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neoplastic Cells, Circulating
5
Multiple Myeloma
5
Endometrial Neoplasms
5
Brain Neoplasms
5
Neoplasm, Residual
4
Gastrointestinal Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Renal Cell
4
Adenocarcinoma
4
Thrombosis
3
Skin Neoplasms
3
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Urination
1
Transurethral Resection of Prostate
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Finasteride
1
Dutasteride
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Prostatic Hyperplasia
×
Blood Specimen Collection
×
Clear all
NCT06116851
2023-11-03
PROMIC
Turku University Hospital
Recruiting
300 enrolled